Teva Fights To Keep Exclusivity On Hypertension Drugs
Teva Pharmaceutical Industries Ltd. has launched the latest volley in a spat over Merck & Co.'s Hyzaar and Cozaar, fighting a bid by rival Apotex Inc. to suspend a decision by...To view the full article, register now.
Already a subscriber? Click here to view full article